Correlation Between Tempest Therapeutics and Merck

Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tempest Therapeutics and Merck Company, you can compare the effects of market volatilities on Tempest Therapeutics and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Merck.

Diversification Opportunities for Tempest Therapeutics and Merck

0.66

Correlation Coefficient

Tempest Therapeutics  Merck

Poor diversification

The 3 months correlation between Tempest and Merck is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Merck go up and down completely randomly.

Pair Corralation between Tempest Therapeutics and Merck

Given the investment horizon of 90 days Tempest Therapeutics is expected to under-perform the Merck. In addition to that, Tempest Therapeutics is 4.85 times more volatile than Merck Company. It trades about -0.09 of its total potential returns per unit of risk. Merck Company is currently generating about -0.04 per unit of volatility. If you would invest  11,663  in Merck Company on August 7, 2024 and sell it today you would lose (1,476) from holding Merck Company or give up 12.66% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Tempest Therapeutics  vs.  Merck Company

Tempest Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tempest Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Merck Company

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with Tempest Therapeutics and Merck

The main advantage of trading using opposite Tempest Therapeutics and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.

The idea behind Tempest Therapeutics and Merck Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.